General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-09 | 2024-03 | -0.35 | -0.3 | 0.05 | 14.29% |
2024-02-29 | 2023-12 | -0.39 | -0.31 | 0.08 | 20.51% |
2024-02-29 | 2023-12 | -0.39 | N/A | N/A | N/A |
2023-11-09 | 2023-09 | -0.45 | -0.34 | 0.11 | 24.44% |
2023-11-09 | 2023-09 | -0.45 | N/A | N/A | N/A |
2023-08-09 | 2023-06 | -0.47 | -0.38 | 0.09 | 19.15% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-15 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-16 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | Oppenheimer | Upgrade | Outperform | Outperform |
2023-03-19 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-01 | Oppenheimer | Upgrade | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2023-09-14 | ALLAND LEILA | Officer | 45.91K | Sale |
2021-06-13 | EUCLIDEAN CAPITAL, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2021-05-31 | HEYMAN RICHARD A | Director | 0.00 | Sale |
2024-01-17 | JALOTA DEEPIKA | Officer | 125.50K | Stock Award(Grant) |
2022-11-24 | KUNG WINSTON | Chief Operating Officer | 10.60K | Stock Gift |
2021-09-21 | LEVINE ARNOLD J | Director | 409.84K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Orbimed Advisors LLC. | 6.56M | 41.08M | 13.54% |
2023-06-29 | Blackrock Inc. | 4.68M | 29.28M | 9.65% |
2023-06-29 | JP Morgan Chase & Company | 4.08M | 25.51M | 8.41% |
2023-06-29 | Boxer Capital, LLC | 3.16M | 19.81M | 6.53% |
2023-06-29 | Avoro Capital Advisors LLC | 3.06M | 19.16M | 6.32% |
2023-06-29 | RTW Investments LP | 3.03M | 18.96M | 6.25% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.26M | 7.90M | 2.61% |
2023-06-29 | JP Morgan Small Cap Growth Fund | 1.23M | 7.73M | 2.55% |
2023-08-30 | iShares Russell 2000 ETF | 904.22K | 6.53M | 1.87% |
2023-07-30 | Federated Hermes MDT Small Cap Core Fund | 818.47K | 5.35M | 1.69% |
2023-06-29 | ACAP Strategic Fund | 709.50K | 4.44M | 1.46% |
2023-06-29 | Vanguard Extended Market Index Fund | 448.37K | 2.81M | 0.93% |
Still looking good. How can we sell this stock while Buy Recommendations are flooding from everywhere.
That > 1M volume on Friday was impressive. Somebody is jumping on the boat with us. We saw a 2 handle and that is far from over. Holding. Technicals are looking good.
It’s just the beginning. Hold
Back to $2 in no time.
Something is definitely cooking here. Holding
Like what we are seeing this morning. Decent volume and green on an ugly day. Something is cooking. Yesterday’s drop was on no volume at all. Holding.
Down on no reason and no volume. Buying this weakness
Finally people are realizing the value of this company. Holding strong for sure. A 3 handle is coming.
Decent Volume. This guy wants to go. Holding strong. Patience is a virtue.
Last time we had such volume was on Feb 14. Someone unloaded a chunk of stock at $1,48 and then we rallied all the way to $1,90
Looks like now someone, once again, is selling a good chunk between $1,50 and $1,60. Once the seller is out of the way we should see less pressure and a blue sky in front of us. GLTA. I’m holding
Old news but stay with it. One day…
Got to like the price action in the last few days. Market is under pressure but we are holding very well. Looking forward to read what will come up in the TD Cowen presentation. Last day tomorrow. Hope for the best.
Wow, we looked good for a while. What happened here !
Only the beginning. Wait until the real volume shows up. Let it go and enjoy. Not a seller for sure. A 2 handle is in the cards. Stay strong and let the dime flippers make their small profits.
The fact that IOVA has been approved by FDA for their melanoma treatments and the stock gaining 60% in the last 2 days is probably one of the reason PMVP is moving higher. Both companies going through trials on cancer treatments. IOVA pipelines is way ahead of PMVP but we shall give a chance for PMVP to prove itself. I can only salute such companies working on fighting cancer.
Volume picking up for the close. Just the beginning. Holding strong
En route to $1.80. Not selling for sure. Something will have to come out from management. Staying with you guys.